In Europe and the Western World in particular, the proportion of older people is dramatically increasing, which is predicted to add tremendous extra pressure to the strained healthcare systems.
Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid-lowering and glucose-lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.
Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalised therapy to older people, which in turn will have a positive impact on services and patient outcomes.
- Prof. Juan Tamargo, Spain
- Prof. Juan Carlos Kaski, UK
WG Member fee *
Students/Trainees/Nurses fee **
* Individuals must be a member of the ESC WG CVP at the moment of their registration in order to benefit from the member fee
** Proof of status will be required (letter from University, etc)
Reduction of cardiovascular disease burden by pharmacotherapy is a multistep approach, which requires to:
- identify new potential drugs;
- test new potential pharmacological compounds in trial setting;
- get regulatory approval;
- implement therapies in clinical practice.
Older patients with cardiovascular disease are often found to be undertreated. There are many reasons for this, including polypharmacy, fear of side effects, co-morbidities, frailty and sparse trial evidence of drug efficacy in the elderly. Strategies leading to the rational implementation of pharmacological therapies are therefore necessary for the subgroup of older patients with cardiovascular disease.
The specific aim of the course is to improve the practicing physician’s competence and confidence to deliver better, safer, personalised therapy for older people, which should, in turn, have a positive impact on patient outcomes and quality of life.
Download the programme
The programme is subject to change.
The programme is currently under review by UEMS for EACCME accreditation.
Feedback from previous courses
What past participants say
- Over 90% of participants found the course extremely useful and useful to their daily practice
- More than 80% rated the programme as 'excellent', with the speakers and topics as the most cited best aspects of the event
- 95% of participants declared that the event fulfilled their educational goals and expected learning outcomes
For any questions, please contact us at email@example.com.